Literature DB >> 25376025

Understanding the adverse effects of ocriplasmin.

David C Beebe1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25376025     DOI： 10.1001/jamaophthalmol.2014.4484

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  7 in total

1.  Acute ocriplasmin retinopathy.

Authors:  Mark W Johnson; Abigail T Fahim; Rajesh C Rao
Journal:  Retina       Date:  2015-06       Impact factor: 4.256

2.  Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.

Authors:  Ricarda G Schumann; Julian Langer; Denise Compera; Katharina Luedtke; Markus M Schaumberger; Thomas Kreutzer; Wolfgang J Mayer; Armin Wolf; Siegfried G Priglinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-28       Impact factor: 3.117

Review 3.  Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications.

Authors:  Irini Chatziralli; George Theodossiadis; Paraskevi Xanthopoulou; Michael Miligkos; Sobha Sivaprasad; Panagiotis Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-30       Impact factor: 3.117

Review 4.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17

5.  Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris.

Authors:  Roghayyeh Baghban; Safar Farajnia; Younes Ghasemi; Reyhaneh Hoseinpoor; Azam Safary; Mojtaba Mortazavi; Nosratollah Zarghami
Journal:  Biol Proced Online       Date:  2020-12-13       Impact factor: 3.244

6.  Engineering of Ocriplasmin Variants by Bioinformatics Methods for the Reduction of Proteolytic and Autolytic Activities.

Authors:  Roghayyeh Baghban; Safar Farajnia; Younes Ghasemi; Mojtaba Mortazavi; Samaneh Ghasemali; Mostafa Zakariazadeh; Nosratollah Zarghami; Nasser Samadi
Journal:  Iran J Med Sci       Date:  2021-11

Review 7.  Ocriplasmin for Treatment of Vitreomacular Traction: An Update.

Authors:  Mohammed Ali Khan; Julia A Haller
Journal:  Ophthalmol Ther       Date:  2016-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.